The U.S. Drug Enforcement Administration (DEA) is highly focused on Mexican cartels in its latest national threat assessment, but it also raises concerns about Canada, citing the presence of large-scale, sophisticated fentanyl laboratories in the country.
In the section on fentanyl, a powerful synthetic opioid responsible for a large number of overdose deaths in the United States and Canada, the DEA says Mexican transnational criminal organizations have “cemented” their role in supplying the drug.
The agency says cartels are capitalizing on the ease of production of synthetic drugs, with precursors coming mostly from China and India, and rely on a “complex and robust” network to smuggle all types of narcotics into the United States.
The DEA mentions Canada as a source of fentanyl production, and as a destination point for shipments of precursor chemicals. The assessment also cited the agency’s “growing concern” over large-scale “super laboratories” operating in Canada.
“In addition to the synthetic drug threat from Mexico, elevated synthetic drug production in Canada—particularly from sophisticated fentanyl ’super laboratories” such as the type seized by the Royal Canadian Mounted Police in October 2024—presents a growing concern for the United States,” says the report.
There are limited mentions of Canada in the DEA report compared to Mexico, and it notes that estimated amounts of fentanyl coming from the north are “substantially lower” than from the south. The DEA says that as of spring 2025, 22.7 kilograms of fentanyl sourced back to Canada were seized at the border in 2024. In comparison, 9,354 kilograms were seized at the border with Mexico.
“Nevertheless, these operations have the potential to expand and fill any supply void created by disruptions to Mexico-sourced fentanyl production and trafficking,” says the DEA.
Canadian federal departments have been sending mixed messages on the impact of domestic production of illicit fentanyl.
Tariff Issue
Fentanyl in Canada became a key issue of criticism from the United States after U.S. President Donald Trump won the November 2024 election. Shortly after, he said he would impose broad tariffs on Canada and Mexico over border security and drug trafficking concerns.In response, Canada presented a border security plan supported by $1.3 billion in investments and designated Mexican cartels as terrorist organizations, while Mexico said it was sending 10,000 troops to the border. Trump went ahead with the tariffs anyway in March, which were amended with exemptions for goods covered by the North American free trade deal.
In recent messaging, the Canadian government has not downplayed the threat from fentanyl.
During his visit at the White House on May 6, Prime Minister Mark Carney called Trump a “transformational president” with a “relentless focus on the American worker, securing your border, ending the scourge of fentanyl.”
Carney added he’s been elected to “transform transform Canada with a similar focus on the economy, securing our borders, again, on fentanyl, much greater focus on defence and security.”